Australian Clinical Labs Ltd Financial Overview
Australian Clinical Labs Ltd's market cap is currently AU$525.69M. The company's EPS TTM is AU$0.116; its P/E ratio is 15.86; and it has a dividend yield of 4.72%. Australian Clinical Labs Ltd is scheduled to report earnings on August 25, 2025, and the estimated EPS forecast is AU$0.07. See an overview of income statement, balance sheet, and cash flow financials.
